恶性胸腹水的胸腹腔内药物治疗  

Summary of the treatment of malignant hydrothorax and abdomen intraperitoneal drugs

作　　者：罗旻[1] 鲁亮[1] 刘云聪[1] Luo Min;Lu Liang;Liu Yuncong(Guizbou Provincal People＇s Hospital,Guizhou Guiyang 550002,China)

机构地区：[1]贵州省人民医院,贵州贵阳550002

出　　处：《医药前沿》2018年第19期12-14,共3页Journal of Frontiers of Medicine

摘　　要：恶性胸腹水是晚期恶性肿瘤患者最常见的并发症。行胸腹水引流后胸腹膜腔内注射硬化剂、化疗药物、生物制剂、抗血管生成药物是目前常用的局部治疗手段，对控制胸腹水生成具有一定作用。Malignant pleural effusion is the most common complication in patients with advanced mallet tumors. Chest water drainage chest peritoneal cavity after injection of hardener, chemotherapy drugs, biologics, anti-angiogenesis drugs is now commonly used local treatment, to control the chest water generated has certain effect.

关 键 词：胸水 腹水 药物疗法 

分 类 号：R730.53[医药卫生—肿瘤]